Vascular smooth muscle cell cytotoxicity and sustained inhibition of neointimal formation by fibroblast growth factor 2-saporin fusion protein

Circulation Research

Volumn 80, Issue 4, 1997, Pages 542-550

  Farb, Andrew ^a   Lee, Sue J ^a   Min, Duk H ^a   Parandoosh, Zahra ^b   Cook, Jennifer ^b   McDonald, John ^b   Pierce, Glenn F ^b   Virmani, Renu ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

^b Prizm Pharmaceuticals Inc   (United States)

Author keywords

fibroblast growth factor; neointima; restenosis; saporin

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; RECOMBINANT FIBROBLAST GROWTH FACTOR; SAPORIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY INJURY; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VASCULAR SMOOTH MUSCLE;

EID: 0031003282     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.80.4.542     Document Type: Article

References (28)

1. McNeil P, Muthukrishnan L, Warder E, D'Amore PA. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol. 1989;109:811-822.
2. Gajdusek CM, Carbon S. Injury-induced release of basic fibroblast growth factor from bovine aortic endothelium. J Cell Physiol. 1989;139:570-579.
3. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991;68:106-113.
4. Edelman ER, Nugent MA, Smith LT, Karnovsky MJ. Basic fibroblast growth factor enhances the coupling of intimal hyperplasia and proliferation of vasa vasorum in injured rat arteries. J Clin Invest. 1992;89:465-473.
5. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991;88:3739-3743.
6. Olsen NE, Chao S, Lindner V, Reidy MA. Intimal smooth muscle cell proliferation after balloon catheter injury: the role of basic fibroblast growth factor. Am J Pathol. 1992;140:1017-1023.
7. Lindner V, Reidy MA. Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries: an en face study. Circ Res. 1993;73:589-595.
8. Epstein SE, Siegall CB, Biro S, Fu YM, FitzGerald D, Pastan I. Cytotoxic effects of a recombinant chimeric toxin on rapidly proliferating vascular smooth muscle cells. Circulation. 1991;84:778-787.
9. Biro S, Siegall CB, Fu Y-M, Speir E, Pastan I, Epstein SE. In vitro effects of a recombinant toxin targeted to the fibroblast growth factor receptor on rat vascular smooth muscle and endothelial cells. Circ Res. 1992;71:640-645.
10. Lappi DA, Maher PA, Martineau D, Baird A. The basic fibroblast growth factor-saporin mitotoxin acts through the basic fibroblast growth factor receptor. J Cell Physiol. 1991;147:17-26.
11. Lappi DA, Baird A. Mitotoxins: growth factor-targeted cytotoxic molecules. Prog Growth Factor Res. 1990;2:223-226.
12. Beitz JG, Davol P, Clark JW, Kato J, Medina M, Frackelton AR Jr, Lappi A, Baird A, Calabresi P. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo. Cancer Res. 1992;52:227-230.
13. David T, Tassin J, Lappi DA, Baird A, Courtois Y. Biphasic effect of the mitotoxin bFGF-saporin on bovine lens epithelial cell growth: effect of cell density and extracellular matrix. J Cell Physiol. 1992;153:483-490.
14. Casscells W, Lappi DA, Olwin BB, Wai C, Siegman M, Speir EH, Sasse J, Baird A. Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci U S A. 1992;89:7159-7163.
15. Lappi DA, Ying W, Barthelemy I, Martineau D, Prieto I, Benatti L, Soria M, Baird A. Expression and activities of a recombinant basic fibroblast growth factor-saporin fusion protein. J Biol Chem. 1994;269:12552-12558.
16. McDonald JR, Ong M, Shen C, Parandoosh Z, Sosnowski B, Bussell S, Houston LL. Large-scale purification and characterization of recombinant fibroblast growth factor-saporin mitotoxin. Protein Expr Purif. 1996;8:97-108.
17. Kolodgie FD, Jacob A, Wilson PS, Carlson GC, Farb A, Verma A, Virmani R. Estradiol attenuates directed migration of vascular smooth muscle cells. Am J Pathol. 1996;148:969-976.
18. Danilenko DM, Ring BD, Tarpley JE, Morris B, Van GW, Morawiecki A, Callahan W, Goldenberg M, Hershenson S, Pierce GF. Growth factors in porcine full and partial thickness burn repair: differing targets and effects of keratinocyte growth factor, platelet-derived growth factor-BB, epidermal growth factor, and neu differentiation factor. Am J Pathol. 1995;147:1261-1277.
19. Mattar SG, Hanson SR, Pierce GF, Chen C, Hughes JD, Cook JE, Shen C, Noe BA, Suwyn CR, Scott JR, Lumsden AB. Local infusion of FGF-saporin reduces intimal hyperplasia. J Surg Res. 1996;60:339-344.
20. Chen C, Mattar SG, Hughes JD, Pierce GF, Cook JE, Ku DN, Hanson SR, Lumsden AB. Recombinant mitotoxin basic fibroblast growth factor-saporin reduced venous anastomotic intimal hyperplasia in the arteriovenous graft. Circulation. 1996;94:1989-1995.
21. Hughes SE, Hall PA. Overview of the fibroblast growth factor and receptor families: complexity, functional diversity, and implications for future cardiovascular research. Cardiovasc Res. 1993;27:1199-1203.
22. Renko M, Quarto N, Morimoto T, Rifkin DB. Nuclear and cytoplasmic localization of different basic fibroblast growth factor species. J Cell Physiol. 1990;144:108-114.
23. Abraham JA, Mergia A, Whang JL, Tumolo A, Friedman J, Hjerrild KA, Gospodarowicz D, Fiddes JC. Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor. Science. 1986;233:545-548.
24. Florkiewicz RZ, Majack RA, Buechler RD, Floridewicz E. Quantitative export of FGF-2 occurs through an alternative, energy- dependent, non-ER/Golgi pathway. J Cell Physiol. 1995;162:388-399.
25. Vlodavsky I, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, Bar-Shavit R, Klagsbrun M. Extracellular matrix-resident basic fibroblast growth factor: implication for the control of angiogenesis. J Cell Biochem. 1991;45:167-176.
26. Gonzalez AM, Buscaglia M, Ong M, Baird A. Distribution of basic fibroblast growth factor in the 18-day rat fetus: localization in the basement membranes of diverse tissues. J Cell Biol. 1990;110:753-765.
27. Vlodavsky I, Folkman J, Sullivan R, Friedman R, Ishai-Michaeli R, Sasse J, Klagsbrun M. Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A. 1987;84:2292-2296.
28. Reidy MA. Neointimal proliferation: The role of basic FGF on vascular smooth muscle cell proliferation. Thromb Hemost. 1993;70:172-176.